Supplements

Guidelines in Practice supplements provide expert opinion articles on a range of clinical and commissioning areas. Our supplement range includes the following types: Product Review; Guidance Update; Local Implementation. Items may contain pharmaceutical promotional information.

FINAL index image

Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*

Commissioned by Accord UK Ltd

Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021

20210329 Prostap RTD_final COVER

Prostap® DCS (leuprorelin acetate)—a 3-monthly gonadotrophin-releasing hormone (GnRH) agonist treatment for breast cancer

Commissioned by Takeda UK Ltd

Information intended for UK healthcare professionals only. This round-table discussion supplement has been commissioned and funded by Takeda UK Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
C-APROM/UK/PRS/0152
Date of preparation: April 2021

Final version - GiP supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103451 Date of preparation: January 2021

GiP Index Image

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice
View prescribing information
PC-GB-103142 November 2020

Front cover 20201202 Plenvu supplement December 2020 PI

Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK

Commissioned by Norgine Pharmaceuticals Limited

This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021

Emollient supplement_Index image

Recommending emollients for patients with atopic dermatitis or dry skin conditions

Commissioned by L’Oréal (UK) Limited

This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines
Date of preparation: January 2021

Index image_Soprobec supplement_PI update

Practical tips for maintaining asthma care prompted by a supply issue during the COVID-19 pandemic

Commissioned by Glenmark Pharmaceuticals Europe Ltd

This supplement has been commissioned and funded by Glenmark Pharmaceuticals Europe Ltd and developed in partnership with Guidelines in Practice.
View prescribing information
PP-UK-SOP-0129 December 2020

Diabetes equipment vector

Showcasing local best practice in diabetes

This Guidelines in Practice supplement aims to showcase local best practice in the diagnosis and management of diabetes. The supplement includes articles from three local initiatives that have developed their own guidance or demonstrated improvements in different areas of diabetes care:

Optimised patient pathway for infertility

An optimised patient pathway for the treatment of heterosexual patients with infertility

Commissioned by Merck Serono Ltd

This supplement has been commissioned and funded by Merck Serono Ltd and developed in partnership with Guidelines in Practice.

Malnutrition supplement

Identification and management of patients with malnutrition

Commissioned by Alliance Pharmaceuticals Ltd

This supplement has been commissioned and funded by Alliance Pharmaceuticals Ltd and developed in partnership with Guidelines in Practice.

Biosimilar insulin WPG

Guideline for the managed introduction of biosimilar basal insulin

Supported by an educational grant from Mylan

This working party guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.